FDA NDC Directory · JSON-LD · Markdown

Tafluprost

NDC 50742-339 · HUMAN PRESCRIPTION DRUG · SOLUTION/ DROPS

Labeler / ManufacturerIngenus Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA218002
Dosage form / routeSOLUTION/ DROPS · OPHTHALMIC
Active ingredientsTAFLUPROST (.015 mg/mL)
Marketing started20241218
Package count1

External sources

Source: openFDA. Public-domain (CC0).